Using an in-vitro assay, we assessed if Sox2 regulates the invasiveness of two ER + breast cancer cell lines (i.e., MCF7 and ZR751), both of which have shown the highest expression level of Sox2 described in our previous study[39]. This evidence concerns the gene SOX2 and breast cancer.